Until it is decided that we go private board or not, as an
Top 10 Most Recent News Articles
Atrium's ATR 1072 Doses First in Genetic Cardiomyopathy Trial
Atrium's Leap in Genetic Cardiomyopathy You know you're living in fascinating times when a company like Atrium Therapeutics rolls the dice on RNA therapeutics, aiming to tackle heart diseases at the genetic level. And that's precisely what they did! They just dosed the first patient in the Phase 1/2 Corventis trial with their drug ATR 1072, setting sail on uncharted...
Continue Reading
Honeywell Aerospace Faces Lawsuit After Stock Tumbles 23%
Honeywell's Bumpy Ride Rattles Investors Something's brewing over at Honeywell Aerospace, Inc. (NASDAQ:HONA) and it's not your regular cup of joe. Investors, brace yourselves, because a securities fraud class action lawsuit is stacking up against them. With shares plummeting 23.16% in a whirlwind of a market day, it's kind of hard not to get a little riled up, isn't it?...
Continue Reading
Bladex Declares Quarterly Dividend for Q3 2026
Bladex's Steady Dividend: What's Under the Hood? Well, well, it looks like Bladex is doing the old dividend dance again. They've just announced a quarterly cash dividend of $0.6875 per share for the third quarter of 2026. It's scheduled for payout on November 24 to those who have their noses in the ledger come November 6—that's your record date, folks. Now, dividends...
Continue Reading
Philips’ Beauty Tech Trends Promise Intimacy by 2027
Beauty Tech Takes a Personal Turn It's 2026, and in the beauty industry, folks are trading flashy for the intimate and intelligent. Philips, that stalwart of tech innovation, is waving the banner, revealing three beauty trends we can't ignore if we plan to keep up with the times. The Rise of Intelligent Guidance First off, everyone and their dog seems to ask how tech is...
Continue Reading
Bank of America Faces Class-Action Suit in Court
Mixed Bag for Bank of America Investors If you thought you could just park your cash in big banks and slumber through the financial year, think again. Bank of America (NYSE: BAC) has found itself in hot water with a securities fraud class-action suit looming over what some are calling a pretty nasty oversight in compliance. A 4.76% stock drop was a bitter sip for those...
Continue Reading
Flagstar Faces Heat: 9.2% Stock Drop Spurs Probe
Flagstar's Descent: What Led to the Stock Tumble? And here we go again with a big name in finance taking a hit right between the eyes. Flagstar Bank, under ticker NYSE:FLG, saw its shares plummet by over 9.2% on October 23, 2026. This isn't just a blip—it's a spill. The backdrop here is an eye-watering $12.9 billion loan book tied to rent-regulated apartment buildings....
Continue Reading
Preston Dermatology Earns Gold in Raleigh Awards
Celebrating a Winning Streak Stroll around Raleigh, and you'll hear buzz about Preston Dermatology & Skin Surgery Center clinching Gold in the annual Raleigh's Best Awards for the second year running. This dermatology practice isn't just another name in the area—it's become a beacon for people seeking quality skin care around the Triangle. Both the practice and its...
Continue Reading
Epic Oceanside Estate Set for No-Reserve Luxury Auction
Going, Going, Gone? A Golf Exec's Dream Home What's hotter than Florida's summer sun? It's this swanky estate at Ponte Vedra Beach set to hit the auction block without any safety net. Yup, no reserve, folks! Leonard "Len" Brown, Jr., the brains behind many of PGA Tour's global ventures, has decided to put his lavish 3.2-acre plot right by the ocean up for grabs. Once...
Continue Reading
Lear Capital Hits $5 Billion Milestone: Trust or Hype?
A Golden Milestone or Just Glitter? Lear Capital's announcement of surpassing $5 billion in precious metals transactions feels like one of those moments where you tilt your head and ask, "Is it really what it seems?" With nearly 150,000 customers and almost three decades of hustling in the glittering world of gold and silver, they've certainly carved out a name in the...
Continue Reading
SLM Hit by Earnings Miss: Shareholders Eye Legal Action
When A Profit Turns To Loss There's a certain sting that comes with expecting a profit only to get smacked with a loss. You know the kind—like when SLM Corporation shareholders had their expectations shattered on October 22, 2026. They figured they'd see a $0.17 profit per share, but what landed instead was a $0.19 loss. That's a $0.36-per-share swing, enough to make...
Continue ReadingTop 5 Most Recently Viewed Articles
UniCredit and Google Cloud Join Forces for Digital Evolution
UniCredit's Strategic Alliance with Google Cloud The recent partnership between UniCredit and Google Cloud is set to pave the way for significant advancements in the banking industry. This strategic agreement aims to modernize UniCredit's operations, enhancing the bank's digital infrastructure and service offerings. By leveraging Google Cloud's innovative technologies,...
Continue Reading
Mohr Capital Expands Portfolio with Major Real Estate Deal
Mohr Capital Makes Significant Acquisition In a strategic move, Mohr Capital, a well-regarded real estate investment firm based in Dallas, has successfully acquired two industrial properties through an 18-year sale leaseback transaction. This acquisition is a testament to their ongoing commitment to expanding their investment portfolio with high-quality assets. Details of...
Continue Reading
Understanding Market Trends in Corning's Options Trading
Bearish Sentiment Among Investors Recently, there has been noticeable bearish sentiment among large investors in Corning. The market dynamics reflect a cautious approach towards this stock as traders navigate uncertain economic conditions. Analysis of Options Trading Activity When examining the options trading history for Corning (NYSE: GLW), a total of 29 trades have...
Continue Reading
NanOlogy Announces David J. Arthur as New CEO to Lead Strategy
NanOlogy Appoints David J. Arthur as Chief Executive Officer NanOlogy, LLC, a company focused on advancing clinical-stage oncology, has announced the appointment of David J. Arthur as its new Chief Executive Officer. This significant move is expected to enhance NanOlogy's progression in the development of its Large Surface Area Microparticle (LSAM) drug portfolio,...
Continue Reading
Engaging Investors: Sapience Therapeutics at Needham Forum
Sapience Therapeutics Prepares for Annual Investor Forum Sapience Therapeutics, Inc., a clinical-stage biotechnology firm, is excited to announce its engagement at the 4th Annual Needham Private Biotech Company Virtual 1x1 Forum. This prestigious event will take place soon, providing a platform for the company to connect with investors and share its innovative...
Continue Reading